% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • frankfrazzano frankfrazzano Aug 26, 2013 5:56 AM Flag

    Amgen acquires ONXY as predicted and....CLDX value keeps going UP on news!

    and a small Follow on acquisition by AZ pf Amplimmune shows again that Cancer space is very HOT...

    AstraZeneca to buy U.S. cancer firm for up to $500 mln

    LONDON, Aug 26 (Reuters) - AstraZeneca Plc took a further step to bolster its pipeline of new cancer drugs on Monday by agreeing to acquire privately held U.S. biotech company Amplimmune for up to $500 million.

    The deal is the second within 24 hours in the cancer drug space, following Amgen Inc's much larger acquisition of Onyx Pharmaceuticals Inc for about $10.4 billion.

    Amplimmune specialises in developing treatments designed to help the immune system fight cancer and the purchase will give AstraZeneca access to a number of compounds currently in pre-clinical development.

    Amplimmune's product line-up includes AMP-514, an anti-programmed cell death 1 (PD-1) medicine that is expected to ready for testing in patients later this year.

    my thoughts....$500M for a PRECLIN PD-1 in AMP-514.....this should tell you what CDX-1127 is worth! Even more importantly what the space may be worth in BILLIONS in the future as Yervoy paves the way....the more BUYOUTS and MERGERS I see the le$$ I want to sell CLDX at any price!


    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
17.84-0.05(-0.28%)Nov 27 1:00 PMEST